Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Drug Administration Schedule"" wg kryterium: Temat


Tytuł:
Extended-release tacrolimus dosing and outcomes in pediatric and young adult transplant recipients - A single-center experience.
Autorzy:
Huang X; Arnold and Marie Schwartz College of Pharmacy, Long Island University, Brooklyn, New York, USA.; Department of Pharmacy, New York Presbyterian Hospital, New York, New York, USA.
Hapgood K; Department of Pharmacy, The Johns Hopkins Hospital, Maryland, Baltimore, USA.
Allan K; Department of Pharmacy, Children's Hospital Colorado, Colorado, Aurora, USA.
Pruette C; Department of Pediatrics, The Johns Hopkins Hospital, Maryland, Baltimore, USA.
Goswami E; Department of Pharmacy, The Johns Hopkins Hospital, Maryland, Baltimore, USA.
Pokaż więcej
Źródło:
Pediatric transplantation [Pediatr Transplant] 2024 Feb; Vol. 28 (1), pp. e14611. Date of Electronic Publication: 2023 Sep 21.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Tacrolimus*
Kidney Transplantation*/adverse effects
Humans ; Child ; Young Adult ; Immunosuppressive Agents/adverse effects ; Transplant Recipients ; Graft Rejection/prevention & control ; Graft Rejection/drug therapy ; Drug Administration Schedule ; Prospective Studies
Czasopismo naukowe
Tytuł:
Position Statement: Range Orders in the Management of Pain.
Autorzy:
Renner L; Nationwide Children's Hospital, Columbus, Ohio. Electronic address: .
Drew DJ; Retired, University of Minnesota, Fairview, Minnesota.
Smith A; University of Iowa Health Care, Iowa City, Iowa.
Quinlan-Colwell A; Independent Consultant and Educator.
Pokaż więcej
Źródło:
Pain management nursing : official journal of the American Society of Pain Management Nurses [Pain Manag Nurs] 2024 Feb; Vol. 25 (1), pp. 27-28. Date of Electronic Publication: 2023 Nov 18.
Typ publikacji:
Journal Article
MeSH Terms:
Pain*/drug therapy
Nursing Care*
Humans ; Analgesics/therapeutic use ; Pain Management ; Drug Administration Schedule
Czasopismo naukowe
Tytuł:
Managing delayed or missed pregabalin doses in patients with focal epilepsy: a Monte Carlo simulation study.
Autorzy:
Xie H; Department of Pharmacy, Fujian Medical University Union Hospital, Gulou District, 29 Xinquan Road, Fuzhou, 350001, Fujian, China.
Zheng Y; Department of Pharmacy, Fujian Medical University Union Hospital, Gulou District, 29 Xinquan Road, Fuzhou, 350001, Fujian, China.; School of Pharmacy, Fujian Medical University, 88 Jiaotong Road, Fuzhou, 350000, Fujian, China.
Wang C; Department of Pharmacy, Shanghai Chest Hospital, Shanghai Jiao Tong University, 241 West Huaihai Road, Shanghai, 200000, China.
Song S; Department of Neurosurgery, Fujian Medical University Union Hospital, 29 Xinquan Road, Gulou District, Fuzhou, 350001, Fujian, China.
Dai Y; Department of Neurosurgery, Fujian Medical University Union Hospital, 29 Xinquan Road, Gulou District, Fuzhou, 350001, Fujian, China.
Huang X; Department of Neurosurgery, Fujian Medical University Union Hospital, 29 Xinquan Road, Gulou District, Fuzhou, 350001, Fujian, China.
Liu M; Department of Pharmacy, Fujian Medical University Union Hospital, Gulou District, 29 Xinquan Road, Fuzhou, 350001, Fujian, China.
Wu X; Department of Pharmacy, Fujian Medical University Union Hospital, Gulou District, 29 Xinquan Road, Fuzhou, 350001, Fujian, China. .
Pokaż więcej
Źródło:
International journal of clinical pharmacy [Int J Clin Pharm] 2024 Feb; Vol. 46 (1), pp. 150-157. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:
Journal Article
MeSH Terms:
Epilepsies, Partial*/drug therapy
Epilepsy*/drug therapy
Humans ; Pregabalin/pharmacokinetics ; Pregabalin/therapeutic use ; Monte Carlo Method ; Drug Administration Schedule
Czasopismo naukowe
Tytuł:
The first randomized controlled trial in pediatric nephrology: the history of the International Study of Kidney Disease in Children (ISKDC).
Autorzy:
Primack WA; University of North Carolina Kidney Center, Chapel Hill, NC, USA. .
Chevalier RL; Department of Pediatrics, University of Virginia, Charlottesville, VA, USA.
Friedman A; University of Minnesota, Minneapolis, MN, USA.
Lemley KV; University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Norwood VF; Department of Pediatrics, University of Virginia, Charlottesville, VA, USA.
Schwartz GJ; University of Rochester Medical Center, Rochester, NY, USA.
Silverstein D; U.S. Food and Drug Administration, Silver Springs, MD, USA.
Kaskel F; Department of Pediatrics (Montefiore), Albert Einstein College of Medicine, Bronx, NY, USA.
Pokaż więcej
Źródło:
Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2023 Dec; Vol. 38 (12), pp. 3947-3954. Date of Electronic Publication: 2023 Jan 10.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Nephrotic Syndrome*/therapy
Nephrotic Syndrome*/drug therapy
Nephrology*
Kidney Diseases*/therapy
Kidney Diseases*/drug therapy
Child ; Humans ; Recurrence ; Drug Administration Schedule
Czasopismo naukowe
Tytuł:
Effectiveness and safety of once-daily tacrolimus formulations in de novo liver transplant recipients: The PRETHI study.
Autorzy:
Bilbao I; Servicio de Cirugía Hepatobiliopancreática y Trasplantes Digestivos, Hospital Universitario Vall d'Hebron, VHIR, Universidad Autónoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain.
Gómez Bravo MÁ; Hospital Virgen del Rocío, Sevilla, Spain.
Otero A; Hospital de A Coruña, A Coruña, Spain.
Lladó L; Hospital U Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
Montero JL; Unidad de hepatología, Hospital U Reina Sofía, Córdoba, Spain.
González Dieguez L; Liver Unit, Hospital U Central de Asturias, Oviedo, Spain.
Graus J; Hospital Ramón y Cajal, Madrid, Spain.
Pons Miñano JA; Liver Transplant Unit, Hospital Virgen de la Arrixaca, IMIB, Murcia, Spain.
Pokaż więcej
Źródło:
Clinical transplantation [Clin Transplant] 2023 Dec; Vol. 37 (12), pp. e15105. Date of Electronic Publication: 2023 Aug 24.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Transplantation*
Kidney Transplantation*/adverse effects
Adult ; Humans ; Tacrolimus/therapeutic use ; Tacrolimus/pharmacokinetics ; Immunosuppressive Agents/therapeutic use ; Immunosuppressive Agents/pharmacokinetics ; Drug Administration Schedule ; Prospective Studies ; Graft Rejection/drug therapy ; Graft Rejection/etiology ; Transplant Recipients
Czasopismo naukowe
Tytuł:
Impact of obesity on the conversion of immediate-release tacrolimus to extended-release tacrolimus in kidney transplant recipients.
Autorzy:
Newman J; Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina, USA.
Patel N; Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina, USA.
Patel S; Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina, USA.
Sprague T; Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina, USA.
Bartlett F; Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina, USA.
Rao N; Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Andrade E; Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Rohan V; Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
DuBay D; Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Casey MJ; Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, South Carolina, USA.
Taber D; Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.; Department of Pharmacy, Ralph H Johnson VAMC, Charleston, South Carolina, USA.
Pokaż więcej
Źródło:
Clinical transplantation [Clin Transplant] 2023 Dec; Vol. 37 (12), pp. e15149. Date of Electronic Publication: 2023 Oct 03.
Typ publikacji:
Journal Article
MeSH Terms:
Tacrolimus*/therapeutic use
Kidney Transplantation*/adverse effects
Humans ; Immunosuppressive Agents/therapeutic use ; Retrospective Studies ; Longitudinal Studies ; Delayed-Action Preparations ; Drug Administration Schedule ; Obesity/drug therapy ; Obesity/surgery ; Obesity/etiology ; Transplant Recipients ; Graft Rejection/drug therapy ; Graft Rejection/etiology
Czasopismo naukowe
Tytuł:
Comparison of amoxicillin administered twice and three times daily in children with acute otitis media.
Autorzy:
Storch-De-Gracia P; Emergency Department, Hospital Infantil Universitario Niño Jesús, Avenida Menéndez Pelayo 65, Madrid, Spain. .; Instituto de Investigación Sanitaria La Princesa, Madrid, Spain. .
Antoñanzas-Bernar V; Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Vergara-Muñoz B; Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Lamagrande-Casanova N; Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Di Campli-Zaghlul M; Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Suárez-Bustamante M; Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Añón-Hidalgo J; Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Maiques M; Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Pokaż więcej
Źródło:
European journal of pediatrics [Eur J Pediatr] 2023 Dec; Vol. 182 (12), pp. 5599-5605. Date of Electronic Publication: 2023 Oct 10.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Amoxicillin*/adverse effects
Otitis Media*/drug therapy
Child ; Humans ; Infant ; Acute Disease ; Drug Administration Schedule ; Drug Therapy, Combination ; Anti-Bacterial Agents/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Retrospective evaluation of LCP-tacrolimus (Envarsus XR) dosing in de novo kidney transplant.
Autorzy:
Alzahrani M; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.
Belcher RM; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.
Benken J; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.; Department of Surgery, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Valdepenas B 3rd; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.
Di Cocco P; Department of Surgery, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Kajavathanan M; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.
Benken ST; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.
Pokaż więcej
Źródło:
Clinical transplantation [Clin Transplant] 2023 Nov; Vol. 37 (11), pp. e15082. Date of Electronic Publication: 2023 Jul 31.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Tacrolimus*
Kidney Transplantation*
Humans ; Adolescent ; Retrospective Studies ; Drug Administration Schedule ; Immunosuppressive Agents ; Obesity/drug therapy ; Obesity/surgery
Czasopismo naukowe
Tytuł:
Safety and Efficacy of Conversion to Once-Daily Tacrolimus from Twice-Daily Tacrolimus in Pediatric Liver Transplant Recipients.
Autorzy:
An S; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Lee S; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address: .
Rhu J; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Kim JM; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Choi GS; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Joh JW; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Pokaż więcej
Źródło:
Journal of pediatric surgery [J Pediatr Surg] 2023 Oct; Vol. 58 (10), pp. 2054-2058. Date of Electronic Publication: 2023 May 11.
Typ publikacji:
Journal Article
MeSH Terms:
Tacrolimus*/adverse effects
Liver Transplantation*
Humans ; Child ; Immunosuppressive Agents/therapeutic use ; Drug Administration Schedule ; Transplantation, Homologous ; Graft Rejection/prevention & control ; Delayed-Action Preparations
Czasopismo naukowe
Tytuł:
Comparison of the Prolonged- and Immediate-Release Tacrolimus Capsule Formulation: The Patient's View and Medication Satisfaction of Patients After Pediatric Heart Transplantation.
Autorzy:
Paintner P; Department of Pediatric Cardiology and Intensive Care Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Lehner A; Department of Pediatric Cardiology and Intensive Care Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Riley R; Department of Pediatric Cardiology and Intensive Care Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Fischer M; Department of Pediatric Cardiology and Intensive Care Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Kozlik-Feldmann R; Department of Pediatric Cardiology, UKE Hamburg, Hamburg, Germany.
Rosenthal L; Department of Pediatric Cardiac Surgery, Ludwig-Maximilians-University Munich, Munich, Germany.
Orban M; Department of Cardiology, Ludwig-Maximilians-University Munich, Munich, Germany.
Jakob A; Department of Pediatric Cardiology and Intensive Care Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Haas N; Department of Pediatric Cardiology and Intensive Care Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Ulrich S; Department of Pediatric Cardiology and Intensive Care Medicine, Ludwig-Maximilians-University Munich, Munich, Germany. Electronic address: .
Pokaż więcej
Źródło:
Transplantation proceedings [Transplant Proc] 2023 Sep; Vol. 55 (7), pp. 1656-1663. Date of Electronic Publication: 2023 Jul 10.
Typ publikacji:
Journal Article
MeSH Terms:
Tacrolimus*/therapeutic use
Heart Transplantation*/adverse effects
Humans ; Child ; Adolescent ; Young Adult ; Adult ; Retrospective Studies ; Patient Satisfaction ; Drug Administration Schedule ; Immunosuppressive Agents/therapeutic use ; Personal Satisfaction
Czasopismo naukowe
Tytuł:
Hepatocyte proliferation activity in untreated rats, measured by immunohistochemical detection of Ki-67: The effect of age on the repeated-dose liver micronucleus assay.
Autorzy:
Satomoto K; BoZo Research Center Inc., 1284 Kamado, Gotemba-shi, Shizuoka 412-0039, Japan. Electronic address: .
Aoki M; BoZo Research Center Inc., 1284 Kamado, Gotemba-shi, Shizuoka 412-0039, Japan.
Wakita A; BoZo Research Center Inc., 1284 Kamado, Gotemba-shi, Shizuoka 412-0039, Japan.
Yamagata H; BoZo Research Center Inc., 1284 Kamado, Gotemba-shi, Shizuoka 412-0039, Japan.
Mitsumoto T; BoZo Research Center Inc., 1284 Kamado, Gotemba-shi, Shizuoka 412-0039, Japan.
Okamoto T; BoZo Research Center Inc., 1284 Kamado, Gotemba-shi, Shizuoka 412-0039, Japan.
Harada R; ITR Laboratories Canada Inc., 19601 Clark Graham Ave, Baie-D'Urfé, Quebec H9X 3T1, Canada.
Hamada S; BoZo Research Center Inc., 1284 Kamado, Gotemba-shi, Shizuoka 412-0039, Japan.
Pokaż więcej
Źródło:
Mutation research. Genetic toxicology and environmental mutagenesis [Mutat Res Genet Toxicol Environ Mutagen] 2023 Aug-Sep; Vol. 890, pp. 503658. Date of Electronic Publication: 2023 Jul 10.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinogens*/toxicity
Bone Marrow*
Rats ; Animals ; Ki-67 Antigen ; Micronucleus Tests/methods ; Rats, Sprague-Dawley ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Administration, Oral ; Chromosome Aberrations ; Cooperative Behavior ; Societies, Pharmaceutical ; Liver ; Hepatocytes ; Cell Proliferation
Czasopismo naukowe
Tytuł:
Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial.
Autorzy:
Lipton RB; Albert Einstein College of Medicine, Bronx, NY, USA.
Halker Singh RB; Mayo Clinic, Scottsdale, AZ, USA.
Mechtler L; Dent Neurologic Institute, Buffalo, NY, USA.
McVige J; Dent Neurologic Institute, Buffalo, NY, USA.
Ma J; AbbVie, Madison, NJ, USA.
Yu SY; AbbVie, Irvine, CA, USA.
Stokes J; AbbVie, Madison, NJ, USA.
Dabruzzo B; AbbVie, Madison, NJ, USA.
Gandhi P; AbbVie, Madison, NJ, USA.
Ashina M; Danish Headache Center, Rigshospitalet Glostrup, University of Copenhagen, Denmark.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2023 Aug; Vol. 51 (8), pp. 3331024231190296.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Journal Article
MeSH Terms:
Quality of Life*
Piperidines*/administration & dosage
Piperidines*/therapeutic use
Pyridines*/administration & dosage
Pyridines*/therapeutic use
Pyrroles*/administration & dosage
Pyrroles*/therapeutic use
Spiro Compounds*/administration & dosage
Spiro Compounds*/therapeutic use
Calcitonin Gene-Related Peptide Receptor Antagonists*/administration & dosage
Calcitonin Gene-Related Peptide Receptor Antagonists*/therapeutic use
Migraine Disorders*/prevention & control
Humans ; Patient Reported Outcome Measures ; Drug Administration Schedule
Czasopismo naukowe
Tytuł:
Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria.
Autorzy:
Taylor WR; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand. .; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK. .
Hoglund RM; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Peerawaranun P; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.
Nguyen TN; Oxford University Clinical Research Unit, Wellcome Trust Major Oversea Programme, Ho Chi Minh City, Vietnam.
Hien TT; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Clinical Research Unit, Wellcome Trust Major Oversea Programme, Ho Chi Minh City, Vietnam.
Tarantola A; Institut Pasteur du Cambodge, 5 Monivong Boulevard, Phnom Penh, 12201, Cambodia.
von Seidlein L; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Tripura R; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Department of Global Health, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Peto TJ; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Dondorp AM; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Landier J; Shoklo Malaria Research Unit, Mae Sot, Thailand.; Aix-Marseille Université, IRD, INSERM, SESSTIM, Marseille, France.
H Nosten F; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Shoklo Malaria Research Unit, Mae Sot, Thailand.
Smithuis F; Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.
Phommasone K; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Mahosot Hospital, Vientiane, Lao PDR.; Amsterdam Institute for Global Health & Development, Amsterdam, The Netherlands.
Mayxay M; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Mahosot Hospital, Vientiane, Lao PDR.; Institute of Research and Education Development, University of Health Sciences, Vientiane, Lao PDR.
Kheang ST; Center for Health and Social Development (HSD), National Institute for Public Health (NIPH) and University Research Co., LLC (URC), Chey Chumneas, Daun Penh, Phnom Penh, Cambodia.; AQUITY Global Inc, 987 Avenel Farm Dr, Potomac, MD, 20854, USA.
Say C; Center for Health and Social Development (HSD), National Institute for Public Health (NIPH) and University Research Co., LLC (URC), Chey Chumneas, Daun Penh, Phnom Penh, Cambodia.
Neeraj K; University Research Co., LLC Washington DC, 7200 Wisconsin Ave, Bethesda, MD, 20814, USA.
Rithea L; National Center for Parasitology, Entomology and Malaria Control, Khan Sen Sok, Phnom Penh, Cambodia.
Dysoley L; National Center for Parasitology, Entomology and Malaria Control, Khan Sen Sok, Phnom Penh, Cambodia.; Institute of Public Health, Phnom Penh, Cambodia.
Kheng S; National Center for Parasitology, Entomology and Malaria Control, Khan Sen Sok, Phnom Penh, Cambodia.
Muth S; National Center for Parasitology, Entomology and Malaria Control, Khan Sen Sok, Phnom Penh, Cambodia.
Roca-Feltrer A; Malaria Consortium, London, UK.
Debackere M; MSF Belgium Cambodia Malaria Program, Khan Chamkarmon, Phnom Penh, Cambodia.
Fairhurst RM; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, 20852, USA.
Song N; FHI 360 Cambodia Office, Keng Kang III Khan Chamkamon, Phnom Penh, Cambodia.
Buchy P; Institut Pasteur du Cambodge, 5 Monivong Boulevard, Phnom Penh, 12201, Cambodia.; GSK Vaccines, 23 Rochester Park, Singapore, Singapore.
Menard D; Institut Pasteur du Cambodge, 5 Monivong Boulevard, Phnom Penh, 12201, Cambodia.; Unité Génétique du Paludisme Et Résistance, Département Parasites Et Insectes Vecteurs, Institut Pasteur, Paris, France.
White NJ; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Tarning J; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Mukaka M; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2021 Sep 09; Vol. 20 (1), pp. 366. Date of Electronic Publication: 2021 Sep 09.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Administration Schedule*
Antimalarials/*administration & dosage
Malaria, Vivax/*prevention & control
Plasmodium vivax/*drug effects
Primaquine/*administration & dosage
Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Body Weight ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł:
Complexity of Medication Regimens for Children With Neurological Impairment.
Autorzy:
Feinstein JA; Adult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado and Children's Hospital Colorado, Aurora.; Department of Pediatrics, University of Colorado, Aurora.
Friedman H; Pediatric Residency Program, University of Colorado, Aurora.
Orth LE; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora.
Feudtner C; Division of General Pediatrics, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Kempe A; Adult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado and Children's Hospital Colorado, Aurora.; Department of Pediatrics, University of Colorado, Aurora.
Samay S; Research Informatics, Analytics Resource Center, Children's Hospital Colorado, Aurora.
Blackmer AB; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora.
Pokaż więcej
Źródło:
JAMA network open [JAMA Netw Open] 2021 Aug 02; Vol. 4 (8), pp. e2122818. Date of Electronic Publication: 2021 Aug 02.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Drug Administration Schedule*
Chronic Disease/*drug therapy
Medication Adherence/*statistics & numerical data
Nervous System Diseases/*drug therapy
Adolescent ; Child ; Child, Preschool ; Cross-Sectional Studies ; Female ; Humans ; Infant ; Male ; United States
Czasopismo naukowe
Tytuł:
A discrete choice experiment on oral and injection treatment preferences among moderate-to-severe psoriasis patients in Japan.
Autorzy:
Komine M; Jichi Medical University Hospital, Tochigi, Shimotsuke, Japan.
Kim H; Bristol Myers Squibb, Tokyo, Japan.
Yi J; Syneos Health, Tokyo, Japan.
Zhong Y; Bristol Myers Squibb, New York, New York, USA.
Sakai Y; Syneos Health, Tokyo, Japan.
Crawford B; Syneos Health, Tokyo, Japan.
Habiro K; Bristol Myers Squibb, Tokyo, Japan.
Hikichi Y; Bristol Myers Squibb, Tokyo, Japan.
Feldman SR; Atrium Health Wake Forest Baptist, North Carolina, Winston-Salem, USA.
Pokaż więcej
Źródło:
The Journal of dermatology [J Dermatol] 2023 Jun; Vol. 50 (6), pp. 766-777. Date of Electronic Publication: 2023 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Choice Behavior*
Psoriasis*/drug therapy
Adult ; Humans ; Japan ; Drug Administration Schedule ; Patient Preference
Czasopismo naukowe
Tytuł:
Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers.
Autorzy:
Li Y; Translational Medicine and Clinical Pharmacology, Sanofi, Beijing, China.
Li Y; Clinical Trial Center, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Li L; Pharmacokinetics, Dynamics and Metabolism, Sanofi R&D, Shanghai, China.
Xue W; Clinical Trial Center, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Xin K; Global Research and Development, Sanofi, Chengdu, China.
Wang T; Clinical Trial Center, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Shi A; Clinical Trial Center, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China. .
Pokaż więcej
Źródło:
Clinical drug investigation [Clin Drug Investig] 2023 Jun; Vol. 43 (6), pp. 413-420. Date of Electronic Publication: 2023 Jun 03.
Typ publikacji:
Clinical Trial, Phase I; Journal Article
MeSH Terms:
Asian People*
Female ; Humans ; Male ; Administration, Oral ; Area Under Curve ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Healthy Volunteers ; Adolescent ; Young Adult ; Adult ; Middle Aged ; China ; Enzyme Inhibitors/adverse effects ; Enzyme Inhibitors/pharmacokinetics ; Enzyme Inhibitors/therapeutic use
Czasopismo naukowe
Tytuł:
Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trial.
Autorzy:
Park K; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.; Department of Internal Medicine, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, Korea.
Jeon YK; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Kim JH; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Choi Y; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Kim JJ; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Oh SB; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Oh SY; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Hong YJ; Department of Neurology, Uijeongbu St. Mary's Hospital, Catholic University of Korea, Seoul, Korea.
Huh SJ; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
Kim I; Division of Oncology, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea.
Shin SH; Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2023 May 19; Vol. 102 (20), pp. e33638.
Typ publikacji:
Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Neutropenia*/chemically induced
Neutropenia*/prevention & control
Antineoplastic Agents*/adverse effects
Antineoplastic Combined Chemotherapy Protocols*/adverse effects
Granulocyte Colony-Stimulating Factor*/therapeutic use
Humans ; Colorectal Neoplasms/drug therapy ; Carcinoma, Neuroendocrine/drug therapy ; Drug Administration Schedule
Czasopismo naukowe
Tytuł:
Envarsus XR® pharmacokinetics in adolescents post-kidney transplantation - A pilot study.
Autorzy:
ElChaki R; Division of Pediatric Nephrology, Department of Pediatrics, University of California Los Angeles, Los Angeles, California, USA.
Ettenger R; Division of Pediatric Nephrology, Department of Pediatrics, University of California Los Angeles, Los Angeles, California, USA.
Lee S; Department of Pharmaceutical Services, Ronald Reagan UCLA Medical Center, Los Angeles, California, USA.
Chen L; Department of Medicine Statistics Core, University of California Los Angeles, Los Angeles, California, USA.
Gales B; Division of Pediatric Nephrology, Department of Pediatrics, University of California Los Angeles, Los Angeles, California, USA.
Srivastava R; Division of Pediatric Nephrology, Department of Pediatrics, University of California Los Angeles, Los Angeles, California, USA.
Pearl M; Division of Pediatric Nephrology, Department of Pediatrics, University of California Los Angeles, Los Angeles, California, USA.
Pokaż więcej
Źródło:
Pediatric transplantation [Pediatr Transplant] 2023 May; Vol. 27 (3), pp. e14480. Date of Electronic Publication: 2023 Feb 02.
Typ publikacji:
Journal Article
MeSH Terms:
Tacrolimus*
Kidney Transplantation*/methods
Adult ; Humans ; Adolescent ; Child ; Immunosuppressive Agents/adverse effects ; Pilot Projects ; Bayes Theorem ; Graft Rejection/prevention & control ; Graft Rejection/drug therapy ; Drug Administration Schedule ; Delayed-Action Preparations
Czasopismo naukowe
Tytuł:
A randomized clinical trial comparing physician-directed or fixed-dose steroid replacement strategies for incomplete dexamethasone dosing prior to docetaxel chemotherapy.
Autorzy:
Hsu T; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Canada.; Department of Medicine, The University of Ottawa, Ottawa, Canada.
Fergusson D; Department of Medicine, The University of Ottawa, Ottawa, Canada.; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Stober C; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Daigle K; Department of Nursing, The Ottawa Hospital and the Ottawa Hospital Cancer Centre, Ottawa, Canada.
Moledina N; Department of Nursing, The Ottawa Hospital and the Ottawa Hospital Cancer Centre, Ottawa, Canada.
Vandermeer L; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Pond G; Department of Oncology, McMaster University, Hamilton, Canada.
Hilton J; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Canada.; Department of Medicine, The University of Ottawa, Ottawa, Canada.
Hutton B; Department of Medicine, The University of Ottawa, Ottawa, Canada.; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Clemons M; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Canada. .; Department of Medicine, The University of Ottawa, Ottawa, Canada. .; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada. .; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, Canada. .
Pokaż więcej
Corporate Authors:
REaCT investigators
Źródło:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 Jun; Vol. 29 (6), pp. 3113-3120. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Drug Administration Schedule*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Dexamethasone/*therapeutic use
Docetaxel/*therapeutic use
Glucocorticoids/*therapeutic use
Premedication/*methods
Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Dexamethasone/pharmacology ; Docetaxel/pharmacology ; Female ; Glucocorticoids/pharmacology ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł:
Association of Chemotherapy Timing in Pregnancy With Congenital Malformation.
Autorzy:
van Gerwen M; Center for Gynecological Oncology Amsterdam, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Maggen C; Department of Oncology, KU Leuven, Leuven, Belgium.
Cardonick E; Department of Obstetrics and Gynecology, Cooper University Health Care, Camden, New Jersey.
Verwaaijen EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
van den Heuvel-Eibrink M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Shmakov RG; National Medical Research Centre for Obstetrics, Gynaecology and Perinatology named after Academician V.I. Kulakov, Ministry of Healthcare of Russian Federation, Moscow, Russia.
Boere I; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Gziri MM; Department of Obstetrics, Cliniques Universitaires St Luc, Université Catholique de Louvain, Sint-Lambrechts-Woluwe, Belgium.
Ottevanger PB; Department of Medical Oncology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands.
Lok CAR; Center for Gynecological Oncology Amsterdam, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, the Netherlands.; Center for Gynecological Oncology Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Halaska M; University Hospital Kralovske Vinohrady, Third Medical Faculty, Charles University, Prague, Czech Republic.
Shao LT; Cooper Medical School, Rowan University, Camden, New Jersey.
Struys I; Department of Oncology, KU Leuven, Leuven, Belgium.
van Dijk-Lokkart EM; Department of Child and Adolescent Psychiatry & Psychosocial Care, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Van Calsteren K; Department of Obstetrics, University Hospitals, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Fruscio R; Department of Obstetrics and Gynecology, San Gerardo Hospital, Milan, Italy.
Zola P; Department of Surgical Sciences, University of Turin, Turin, Italy.
Scarfone G; Gynecological Oncology Unit, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico, Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, Italy.
Amant F; Center for Gynecological Oncology Amsterdam, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Oncology, KU Leuven, Leuven, Belgium.; Center for Gynecological Oncology Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Pokaż więcej
Corporate Authors:
International Network on Cancer, Infertility and Pregnancy
Źródło:
JAMA network open [JAMA Netw Open] 2021 Jun 01; Vol. 4 (6), pp. e2113180. Date of Electronic Publication: 2021 Jun 01.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Administration Schedule*
Abnormalities, Drug-Induced/*etiology
Antineoplastic Agents/*adverse effects
Antineoplastic Agents/*therapeutic use
Fetal Development/*drug effects
Neoplasms/*drug therapy
Adolescent ; Adult ; Cohort Studies ; Female ; Gestational Age ; Humans ; Middle Aged ; Odds Ratio ; Pregnancy ; Pregnancy Trimester, First ; Pregnant Women ; Time Factors ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies